Dr. Reddy's Laboratories (RDY) Financial Statements
Price: $13.79
Market Cap: $11.49B
Avg Volume: 2.16M
Market Cap: $11.49B
Avg Volume: 2.16M
Country: IN
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Dr. Reddy's Laboratories.
Income Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $279.16B | $245.88B | $214.39B | $189.72B | $174.60B | $153.85B | $142.03B | $140.81B | $154.71B | $148.19B |
| Cost of Revenue | $115.56B | $42.91B | $100.55B | $86.64B | $80.59B | $70.42B | $65.72B | $62.45B | $62.43B | $62.79B |
| Gross Profit | $163.61B | $202.97B | $113.84B | $103.08B | $94.01B | $83.43B | $76.30B | $78.36B | $92.28B | $85.40B |
| Gross Profit Ratio | 58.61% | 82.55% | 53.10% | 54.33% | 53.84% | 54.23% | 53.72% | 55.65% | 59.65% | 57.63% |
| Research and Development Expenses | $22.87B | $19.38B | $17.48B | $16.54B | $15.41B | $15.61B | $18.27B | $19.55B | $17.83B | $17.45B |
| General and Administrative Expenses | $- | $46.47B | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $59.47B | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $77.20B | $105.93B | $62.08B | $54.56B | $50.13B | $48.89B | $46.91B | $46.37B | $45.70B | $42.59B |
| Other Expenses | $-4.20B | $-7.70B | $-2.76B | $-982.00M | $-4.29B | $-691.00M | $-843.00M | $-1.15B | $-986.00M | $-1.06B |
| Operating Expenses | $95.88B | $117.61B | $76.80B | $70.12B | $61.25B | $62.54B | $64.39B | $64.86B | $62.66B | $59.12B |
| Cost and Expenses | $211.44B | $160.52B | $177.35B | $156.76B | $141.84B | $132.96B | $130.11B | $127.31B | $125.09B | $121.90B |
| Interest Income | $2.28B | $1.18B | $3.08B | $2.62B | $888.00M | $2.28B | $540.00M | $558.00M | $1.40B | $1.06B |
| Interest Expense | $1.71B | $1.43B | $958.00M | $970.00M | $983.00M | $1.16B | $788.00M | $634.00M | $826.00M | $1.09B |
| Depreciation and Amortization | $14.84B | $12.64B | $11.82B | $12.80B | $12.47B | $12.19B | $11.71B | $11.28B | $10.25B | $8.10B |
| EBITDA | $88.42B | $74.43B | $47.74B | $45.71B | $41.78B | $31.86B | $23.73B | $24.55B | $40.17B | $35.16B |
| EBITDA Ratio | 31.67% | 30.27% | 22.27% | 24.09% | 23.93% | 20.71% | 16.71% | 17.43% | 25.97% | 23.73% |
| Operating Income | $67.73B | $96.28B | $40.82B | $36.06B | $37.05B | $20.89B | $11.92B | $13.50B | $29.62B | $26.29B |
| Operating Income Ratio | 24.26% | 39.16% | 19.04% | 19.01% | 21.22% | 13.58% | 8.39% | 9.59% | 19.15% | 17.74% |
| Total Other Income Expenses Net | $4.14B | $3.34B | $2.82B | $4.04B | $2.04B | $1.55B | $2.42B | $1.16B | $-2.48B | $1.88B |
| Income Before Tax | $71.87B | $60.48B | $32.30B | $28.32B | $18.03B | $22.44B | $14.34B | $14.65B | $27.14B | $28.16B |
| Income Before Tax Ratio | 25.74% | 24.60% | 15.06% | 14.93% | 10.33% | 14.59% | 10.10% | 10.41% | 17.54% | 19.00% |
| Income Tax Expense | $16.19B | $15.41B | $8.73B | $9.18B | $-1.47B | $3.65B | $4.54B | $2.61B | $7.13B | $5.98B |
| Net Income | $55.68B | $45.07B | $23.57B | $17.24B | $19.50B | $18.80B | $9.81B | $12.04B | $20.01B | $22.18B |
| Net Income Ratio | 19.95% | 18.33% | 10.99% | 9.09% | 11.17% | 12.22% | 6.90% | 8.55% | 12.94% | 14.97% |
| EPS | $66.80 | $54.29 | $28.42 | $20.79 | $23.53 | $22.66 | $11.83 | $14.45 | $23.47 | $26.04 |
| EPS Diluted | $66.80 | $54.17 | $28.34 | $20.73 | $23.48 | $22.62 | $11.80 | $14.42 | $23.40 | $25.95 |
| Weighted Average Shares Outstanding | 833.54M | 830.17M | 829.41M | 829.22M | 828.79M | 829.58M | 829.23M | 833.24M | 852.74M | 851.57M |
| Weighted Average Shares Outstanding Diluted | 833.54M | 831.91M | 831.69M | 831.58M | 830.41M | 830.98M | 830.93M | 834.99M | 855.36M | 854.67M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $7.11B | $5.78B | $14.85B | $14.83B | $2.05B | $2.23B | $2.64B | $18.14B | $39.95B | $39.65B |
| Short Term Investments | $74.36B | $60.97B | $29.51B | $19.74B | $23.69B | $22.53B | $18.33B | $14.27B | $35.03B | $34.26B |
| Cash and Short Term Investments | $81.47B | $66.75B | $44.37B | $34.57B | $25.74B | $24.76B | $20.97B | $18.14B | $39.95B | $39.65B |
| Net Receivables | $80.30B | $72.48B | $66.76B | $49.64B | $50.28B | $39.87B | $40.62B | $38.06B | $41.31B | $40.76B |
| Inventory | $63.55B | $48.67B | $50.88B | $45.41B | $35.07B | $33.58B | $29.09B | $28.53B | $25.58B | $25.53B |
| Other Current Assets | $22.73B | $21.30B | $19.84B | $18.62B | $19.29B | $16.30B | $18.97B | $15.64B | $12.85B | $13.90B |
| Total Current Assets | $248.05B | $204.25B | $181.11B | $148.25B | $130.37B | $114.50B | $109.64B | $100.38B | $119.69B | $119.84B |
| Property Plant Equipment Net | $76.89B | $56.54B | $62.17B | $57.11B | $52.33B | $54.09B | $57.87B | $57.16B | $53.96B | $48.09B |
| Goodwill | $4.25B | $5.47B | $4.42B | $4.57B | $3.99B | $3.90B | $3.94B | $3.75B | $3.85B | $3.38B |
| Intangible Assets | $36.95B | $30.72B | $27.25B | $35.65B | $27.66B | $44.37B | $44.66B | $44.92B | $20.80B | $13.05B |
| Goodwill and Intangible Assets | $41.20B | $36.20B | $31.66B | $40.22B | $31.65B | $48.27B | $48.61B | $48.68B | $24.64B | $16.43B |
| Long Term Investments | $5.25B | $6.09B | $7.99B | $8.33B | $3.09B | $3.34B | $4.65B | $6.84B | $3.30B | $3.85B |
| Tax Assets | $- | $7.05B | $12.78B | $10.63B | $12.21B | $4.17B | $3.63B | $5.58B | $5.00B | $5.79B |
| Other Non-Current Assets | $16.12B | $12.71B | $948.00M | $952.00M | $2.58B | $1.06B | $1.20B | $1.19B | $1.06B | $762.00M |
| Total Non-Current Assets | $139.47B | $118.60B | $115.55B | $117.24B | $101.87B | $110.93B | $115.96B | $119.45B | $87.96B | $74.92B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $387.52B | $322.85B | $296.65B | $265.49B | $232.24B | $225.43B | $225.60B | $219.82B | $207.65B | $194.76B |
| Account Payables | $21.55B | $17.86B | $15.97B | $12.70B | $10.74B | $10.30B | $9.21B | $- | $- | $- |
| Short Term Debt | $14.03B | $12.19B | $28.10B | $24.01B | $20.80B | $16.38B | $25.62B | $43.74B | $22.83B | $28.91B |
| Tax Payables | $2.34B | $2.14B | $5.44B | $1.39B | $573.00M | $181.00M | $1.53B | $1.48B | $2.58B | $2.51B |
| Deferred Revenue | $- | $1.98B | $2.58B | $2.03B | $1.91B | $1.35B | $982.00M | $819.00M | $659.00M | $1.06B |
| Other Current Liabilities | $58.12B | $53.53B | $48.33B | $45.30B | $40.70B | $32.84B | $33.33B | $39.78B | $39.24B | $32.58B |
| Total Current Liabilities | $96.04B | $85.72B | $97.84B | $81.47B | $72.81B | $59.70B | $69.69B | $85.00B | $64.65B | $63.99B |
| Long Term Debt | $5.99B | $1.28B | $5.75B | $6.30B | $1.30B | $22.00B | $25.09B | $5.45B | $10.69B | $15.08B |
| Deferred Revenue Non-Current | $- | $1.55B | $1.60B | $1.53B | $1.96B | $2.00B | $2.70B | $3.17B | $1.53B | $2.11B |
| Deferred Tax Liabilities Non-Current | $- | $760.00M | $60.00M | $338.00M | $275.00M | $610.00M | $730.00M | $1.20B | $767.00M | $1.78B |
| Other Non-Current Liabilities | $4.94B | $2.99B | $2.54B | $2.40B | $3.13B | $3.53B | $4.36B | $5.33B | $3.98B | $4.38B |
| Total Non-Current Liabilities | $10.93B | $4.27B | $8.29B | $9.04B | $4.44B | $25.53B | $29.45B | $10.78B | $14.67B | $19.46B |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $106.97B | $89.99B | $106.13B | $90.51B | $77.25B | $85.23B | $99.14B | $95.78B | $79.31B | $83.46B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $834.00M | $833.00M | $832.00M | $832.00M | $831.00M | $830.00M | $830.00M | $829.00M | $853.00M | $852.00M |
| Retained Earnings | $265.26B | $215.59B | $175.71B | $157.93B | $144.25B | $128.65B | $113.86B | $108.22B | $99.55B | $83.64B |
| Accumulated Other Comprehensive Income Loss | $4.03B | $1.27B | $1.06B | $1.33B | $2.42B | $3.04B | $3.98B | $7.80B | $5.33B | $4.63B |
| Other Total Stockholders Equity | $10.43B | $10.29B | $8.43B | $8.25B | $7.49B | $7.68B | $7.79B | $7.19B | $22.60B | $22.18B |
| Total Stockholders Equity | $280.55B | $232.86B | $190.53B | $174.98B | $154.99B | $140.20B | $126.46B | $124.04B | $128.34B | $111.30B |
| Total Equity | $280.55B | $232.86B | $190.53B | $174.98B | $154.99B | $140.20B | $126.46B | $124.04B | $128.34B | $111.30B |
| Total Liabilities and Stockholders Equity | $387.52B | $322.85B | $296.65B | $265.49B | $232.24B | $225.43B | $225.60B | $219.82B | $207.65B | $194.76B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $387.52B | $322.85B | $296.65B | $265.49B | $232.24B | $225.43B | $225.60B | $219.82B | $207.65B | $194.76B |
| Total Investments | $79.62B | $67.06B | $37.50B | $28.08B | $26.78B | $25.87B | $22.98B | $21.11B | $38.33B | $38.11B |
| Total Debt | $20.02B | $13.47B | $33.84B | $30.31B | $22.10B | $38.38B | $50.71B | $49.19B | $33.51B | $43.13B |
| Net Debt | $12.91B | $7.69B | $18.99B | $15.48B | $20.05B | $36.15B | $48.08B | $31.05B | $-6.44B | $3.47B |
Cash Flow Statement
| Breakdown | March 31, 2024 | March 31, 2023 | March 31, 2022 | March 31, 2021 | March 31, 2020 | March 31, 2019 | March 31, 2018 | March 31, 2017 | March 31, 2016 | March 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $55.68B | $60.48B | $23.57B | $19.15B | $19.50B | $18.80B | $9.81B | $12.04B | $20.01B | $22.18B |
| Depreciation and Amortization | $14.84B | $12.50B | $11.82B | $12.80B | $12.47B | $12.19B | $11.71B | $11.28B | $10.25B | $8.10B |
| Deferred Income Tax | $16.19B | $15.30B | $8.73B | $9.18B | $-1.47B | $3.65B | $4.54B | $2.61B | $7.13B | $5.98B |
| Stock Based Compensation | $821.00M | $397.00M | $592.00M | $584.00M | $521.00M | $389.00M | $454.00M | $398.00M | $471.00M | $498.00M |
| Change in Working Capital | $-20.18B | $-7.86B | $-13.91B | $-8.29B | $-7.54B | $-5.77B | $-8.96B | $-5.35B | $-188.00M | $-15.04B |
| Accounts Receivables | $-8.05B | $-5.75B | $-17.01B | $2.08B | $-12.45B | $1.80B | $-2.10B | $3.04B | $833.00M | $-10.90B |
| Inventory | $-18.45B | $-2.65B | $-5.33B | $-9.88B | $-1.49B | $-8.50B | $-3.23B | $-6.33B | $-2.52B | $-5.45B |
| Accounts Payables | $- | $5.75B | $17.01B | $-2.08B | $12.45B | $-1.80B | $- | $- | $- | $- |
| Other Working Capital | $6.32B | $-5.20B | $-8.59B | $1.59B | $-6.05B | $2.73B | $-5.73B | $975.00M | $2.33B | $-9.59B |
| Other Non Cash Items | $-21.92B | $-21.96B | $-2.69B | $2.29B | $6.35B | $-547.00M | $488.00M | $535.00M | $3.57B | $3.31B |
| Net Cash Provided by Operating Activities | $45.43B | $58.87B | $28.11B | $35.70B | $29.84B | $28.70B | $18.03B | $21.51B | $41.25B | $25.03B |
| Investments in Property Plant and Equipment | $-16.40B | $-18.86B | $-19.05B | $-12.56B | $-6.12B | $-7.49B | $-11.04B | $-40.98B | $-14.88B | $-15.33B |
| Acquisitions Net | $-12.00M | $- | $-326.00M | $-15.51B | $1.27B | $536.00M | $1.75B | $-103.00M | $-7.94B | $-276.00M |
| Purchases of Investments | $-145.49B | $-136.17B | $-88.97B | $-75.42B | $-111.92B | $-78.57B | $-68.43B | $-49.65B | $-68.25B | $-53.47B |
| Sales Maturities of Investments | $129.78B | $112.81B | $77.77B | $79.53B | $111.70B | $76.29B | $64.04B | $71.59B | $69.27B | $45.18B |
| Other Investing Activities | $-8.16B | $859.00M | $4.19B | $1.30B | $137.00M | $1.51B | $-1.20B | $672.00M | $1.37B | $989.00M |
| Net Cash Used for Investing Activities | $-40.28B | $-41.37B | $-26.39B | $-22.66B | $-4.92B | $-7.73B | $-14.88B | $-18.47B | $-20.42B | $-22.90B |
| Debt Repayment | $-1.15B | $-1.01B | $2.73B | $-697.00M | $-19.16B | $-15.18B | $882.00M | $-5.22B | $-11.98B | $-3.72B |
| Common Stock Issued | $805.00M | $368.00M | $334.00M | $269.00M | $4.00M | $- | $1.00M | $1.00M | $1.00M | $206.00M |
| Common Stock Repurchased | $- | $- | $- | $-1.19B | $-474.00M | $-535.00M | $- | $-15.69B | $- | $- |
| Dividends Paid | $-6.65B | $-4.98B | $-4.15B | $-4.15B | $-3.92B | $-4.00B | $-3.99B | $-3.39B | $-4.11B | $-3.07B |
| Other Financing Activities | $3.23B | $-21.23B | $-1.34B | $5.47B | $-2.21B | $-1.61B | $-1.33B | $20.61B | $-1.61B | $3.19B |
| Net Cash Used Provided by Financing Activities | $-3.76B | $-26.86B | $-2.42B | $-298.00M | $-25.16B | $-21.33B | $-4.44B | $-3.69B | $-17.00B | $-4.12B |
| Effect of Forex Changes on Cash | $-59.00M | $286.00M | $733.00M | $113.00M | $-25.00M | $35.00M | $57.00M | $-492.00M | $-4.30B | $-1.07B |
| Net Change in Cash | $1.33B | $-9.07B | $32.00M | $12.86B | $-266.00M | $-314.00M | $-1.24B | $-1.14B | $-473.00M | $-3.06B |
| Cash at End of Period | $7.11B | $5.78B | $14.85B | $14.82B | $1.96B | $2.23B | $2.54B | $3.78B | $4.92B | $5.39B |
| Cash at Beginning of Period | $5.78B | $14.85B | $14.82B | $1.96B | $2.23B | $2.54B | $3.78B | $4.92B | $5.39B | $8.45B |
| Operating Cash Flow | $45.43B | $58.87B | $28.11B | $35.70B | $29.84B | $28.70B | $18.03B | $21.51B | $41.25B | $25.03B |
| Capital Expenditure | $-27.43B | $-18.86B | $-19.05B | $-12.56B | $-6.12B | $-7.49B | $-11.04B | $-40.98B | $-14.88B | $-15.33B |
| Free Cash Flow | $18.00B | $40.01B | $9.06B | $23.14B | $23.73B | $21.21B | $6.99B | $-19.47B | $26.37B | $9.71B |